Mathematical modelling, simulation and prediction of tumour-induced angiogenesis

Invasion and Metastasis

Volumn 16, Issue 4-5, 1996, Pages 222-234

  Chaplain, M A J ^a   Anderson, A R A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Angiogenesis; Mathematical model; Solid tumour

Indexed keywords

ANGIOGENIC FACTOR; FIBRONECTIN;

ANASTOMOSIS; ANGIOGENESIS; ARTHRITIS; CANCER MODEL; CAPILLARY; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; DENDRITE; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; REVIEW; SOLID TUMOR; TUMOR GROWTH; WOUND HEALING;

ANIMALS; COMPUTER SIMULATION; ENDOTHELIUM, VASCULAR; HUMANS; MATHEMATICAL COMPUTING; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0030404170     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Graham CH, Lala PK: Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol 1992;70:867-874.
2. Arnold F, West DC: Angiogenesis in wound healing. Pharmac Ther 1991; 52:407-422.
3. Pettet G, Chaplain MAJ, McElwain DLS, Byrne HM: On the role of angiogenesis in wound healing. Proc Soc Lond [B] 1996;263:1487-1493.
4. Folkman J: Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
5. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995;1:21-31.
6. Muthukkaruppan VR, Kubai L, Auerbach R: Tumor-induced neovascularization in the mouse eye. J Natl Cancer Inst 1982;69:699-705.
7. Folkman J, Brem H: Angiogenesis and inflammation; in Gallin JI, Goldstein JM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates, ed 2. New York, Raven Press, 1992.
8. Madri JA, Pratt BM: Endothelial cell-matrix interactions: In vitro models of angiogenesis. J Histochem Cytochem 1986;34:85-91.
9. Cliff WJ: Observations on healing tissue: A combined light and electron microscopic investigation. Trans R Soc Lond [B] 1963;246:305-325.
10. Schoefl GI: Studies on inflammation. III. Growing capillaries: Their structure and permeability. Virchows Arch Pathol Anat 1963;337:97-141.
11. Warren BA: The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 1966;15:464-473.
12. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis. Microvasc Res 1977;14:53- 65.
13. Sholley MM, Ferguson GP, Seibel HR, Monteur JL, Wilson JD: Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 1984;51:624-634.
14. Paweletz N, Knierim M: Tumor- related angiogenesis. Crit Rev Oncol Hematol 1989;9:197-242.
15. Harris AL, Fox S, Bicknell R, Leek R, Gatter K: Tumour angiogenesis in breast cancer - prognostic factor and therapeutic target. J Cell Biochem 1994;S18D-SID;225.
16. Bennett S, Engel CJ, O'Malley F, Doig G, Chambers A: Tumor angiogenesis predicts metastasis in invasive colorectal cancer. Lab Invest 1995;72:A57.
17. Bikfalvi A: Significance of angiogenesis in tumour progression and metastasis. Eur J Cancer 1995;31A: 1101-1104.
18. Carrau RL, Barnes EL, Snyderman CH, Petruzzelli G, Kachman K, Rueger R, Damico F, Johnson JT: Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous-cell carcinoma of the head and neck. Invas Met 1995;15:197-202.
19. Ellis LE, Fidler U: Angiogenesis and breast cancer metastasis Lancet 1995;346:388-389.
20. Fox SB, Gatter KC, Altman DG, Leek RD, Harris AL: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:1798- 1799.
21. Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB: Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 1995;222:695-699.
22. Gasparini G: Tumour angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:1799-1801.
23. Gasparini G, Harris AL: Clinical importance of the determination of tumour angiogenesis in breast-cancer - much more than a new prognostic tool. J Clin Oncol 1995;13:765-782.
24. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR: Tumor angiogenesis correlates with lymph-node metastases in invasive bladder cancer. J Urol 1995;154:69-71.
25. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y, Sowa M: Tumor angiogenesis and tumor-cell proliferation as prognostic indicators in gastric carcinoma. Brit J Cancer 1995;72:319- 323.
26. Norton JA: Tumor angiogenesis: The future is now. Ann Surg 1995; 222:693-694.
27. Wiggins DL, Granai CO, Steinhoff MM, Calabresi P: Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995;53: 353-356.
28. Engel CJ, Bennett ST, Chambers AF, Doig GS, Kerkvliet N, O'Malleay FP: Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 1996;20:1260-1265.
29. Morphopoulos G, Pearson M, Ryder WD, Howell A, Harris M: Tumor angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol 1996;180:44- 49.
30. Shpitzer T, Chaimoff M, Gal R, Stern Y, Feinmesser R, Segal K: Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch Otolaryngol Head Neck Surg 1996;122:865-868.
31. Herblin WF, Gross JL: Inhibition of angiogenesis as a strategy for tumour growth control. Mol Chem Neuropathol 1994;21:329-336.
32. Harris AL, Zhang HT, Moghaddam A, Fox S, Scott P, Pattison A, Gatter K, Stratford I, Bicknell R: Breast cancer angiogenesis: New approaches to therapy via anti-angiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treatm 1996;38:97-108.
33. Balding D, McElwain DLS: A mathematical model of tumour-induced capillary growth. J Theor Biol 1985; 114:53-73.
34. Stokes CL, Lauffenburger DA: Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J Theor Biol 1991;152:377-403.
35. 5 Chaplain MA J, Stuart AM: A model mechanism for the chemotactic response of endothelial cells to tumour angiogenesis factor. IMA J Math Appl Med Biol 1993;10:149-168.
36. Chaplain MAJ: The mathematical modelling of tumour angiogenesis and invasion. Acta Biotheor 1995;43:387-402.
37. Byrne HM, Chaplain MAJ: Mathematical models for tumour angiogenesis: Numerical simulations and nonlinear wave solutions. Bull Math Biol 1995;57:461-486.
38. Orme ME, Chaplain MAJ: A mathematical model of the first steps of tumour-related angiogenesis: Capillary sprout formation and secondary branching. IMA J Math App Med Biol 1996;13:73-98.
39. Orme ME, Chaplain MAJ: Two-dimensional models of tumour angiogenesis and anti-angiogenesis strategies. IMA J Math App Med Biol 1997; in press.
40. Folkman J, Haudenschild C: Angiogenesis in vitro. Nature 1980;288:551-556.
41. Gimbrone MA, Cotran RS, Leapman SB, Folkman J: Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 1976;52:413-427.
42. Folkman J, Klagsbrun M: Angiogenic factors. Science 1987;235:442- 447.
43. Liotta LA, Rao CN, Barsky SH: Tumour invasion and the extracellular matrix. Lab Invest 1983;49:636- 649.
44. Schor SL, Schor AM, Brazill GW: The effects of fibronectin on the migration of human foreskin fibro- blasts and Syrian hamster melanoma cells into three-dimensional gels of lattice collagen fibres. J Cell Sci 1981;48:301-314.
45. Monaghan P, Warburton MJ, Perusinghe N, Rutland PS: Topographical arrangement of basement membrane proteins in lactating rat mammary gland: Comparison of the distribution of type IV collagen, laminin, fibronectin and Thy-1 at the ultrastructural level. Proc Natl Acad Sci USA 1983;80:3344-3348.
46. Terranova VP, Diflorio R, Lyall RM, Hic S, Friesel R, Maciag T: Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol 1985;101:2330-2334.
47. Stokes CL, Rupnick MA, Williams SK, Lauffenburger DA: Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor. Lab Invest 1990;63:657-668.
48. Carter SB: Principles of cell motility: The direction of cell movement and cancer invasion. Nature 1965;208:1183-1187.
49. Bowersox JC, Sorgente N: Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res 1982;42:2547-2551.
50. Yamada KM, Olden K: Fibronectin-adhesive glycoproteins of cell surface and blood. Nature 1978;275: 179-184.
51. Stokes CL, Lauffenburger DA, Williams SK: Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J Cell Sci 1991;99:419- 430.
52. Anderson ARA, Sleeman BDS, Young IM, Griffiths BS: Nematode movement along a chemical gradient in a structurally heterogeneous environment. II. Theory. Fundam Appl Nematol 1997; in press.
53. Mitchell AR, Griffiths DF: The Finite Difference Method in Partial Differential Equations. Chichester, Wiley, 1980.
54. Lewis J, Slack JMW, Wolpert L: Thresholds in development. J Theor Biol 1977;65:579-590.
55. Wolpert L: Positional information and pattern formation. Phil Trans R Soc Lond[B] 1981;295:441-450.
56. Knighton DM, Silver IA,: Hunt TK: Regulation of wound-healing angiogenesis - effect of oxygen gradients and inspired oxygen concentration. Surgery 1981;90:262-270.
57. Polverini PJ, Cotran RS, Gimbrone MA, Jr, Unanue ER: Activated macrophages induce vascular proliferation. Nature 1977;269:804-806.
58. Knighton DM, Hunt TK, Scheuenstuhl H, Halliday BJ: Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983;221:1283-1285.
59. Lewis CE, Leek R, Harris A, McGee JOD: Cytokine regulation of angiogenesis in breast cancer: The role of tumour-associated macrophages. J Leukocyte Biol 1995;57:747-751.
60. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157- 1164.
61. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Helene Sage E, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79: 315-328.
62. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-641.